© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
September 22, 2016
A recent analysis from Johns Hopkins University Bloomberg School of Public Health researchers found that generic forms of the biologic drug infliximab (remicade) appear to be just as safe and effective as the brand name version.
August 25, 2016
Generic drug manufacturers have long accused their brand name counterparts of exploiting a federal program intended to promote medication safety as a means of blocking generic competition in the pharmaceutical marketplace.
August 24, 2016
The Supreme Court of the United States recently ruled in favor of generic drug manufacturers and advocates for lower drug prices in a patent-law case, the result of which, brand name manufacturing stakeholders argue, hinders continued investments in vital drug research and development.
July 29, 2016
A free online program called Fit2Me allows T2D patients to tailor 4 key areas of diabetes care to their specific needs